Showing results (61-70 of 387) with videos related to
Sort By:
Pageof 39
Molecular Diagnosis & Therapy|July 16, 2022
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?Giovanni Monteleone, Carmine Stolfi, Irene Marafini, et al.Innere Medizin (Heidelberg, Germany)|January 10, 2025
[Treatment of severe flares in Crohn's disease and ulcerative colitis]Andreas Stallmach, Johannes Stallhofer, Carsten Schmidt, et al.Histology and Histopathology|June 2, 2011
Prospective evaluation of the learning curve of confocal laser endomicroscopy in patients with IBDHelmut Neumann, Michael Vieth, Raja Atreya, et al.Current Medicinal Chemistry|August 18, 2010
Anticancer properties of the IL-12 family--focus on colorectal cancerM A Engel, M F NeurathArchives of Toxicology|January 31, 2015
From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesisTimo Rath, Ulrike Billmeier, Maximilian J Waldner, et al.Inflammatory Bowel Diseases|July 3, 2007
Exacerbation of ulcerative colitis after rituximab salvage therapyMartin Goetz, Raja Atreya, Maryam Ghalibafian, et al.Expert Opinion on Biological Therapy|July 27, 2021
A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical Data to Real-World EvidenceFabio Salvatore Macaluso, Jr Fraser Cummings, Raja Atreya, et al.Frontiers in Immunology|July 14, 2026
Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseasesNicole Neurath, Andre Jefremow, Selina Sitte, et al.Gut|November 21, 1998
Role of NF-kappaB in immune and inflammatory responses in the gutM F Neurath, C Becker, K BarbulescuZeitschrift Fur Rheumatologie|June 6, 2018
[What rheumatologists can learn from gastroenterologists]S Fischer, C Beyer, M F NeurathPageof 39